• Users Online: 90
  • Print this page
  • Email this page
CASE REPORT
Year : 2022  |  Volume : 2  |  Issue : 4  |  Page : 906-908

Adalimumab in Vogt–Koyanagi–Harada disease: A case report


1 Medical Department of Nanchang University, Nanchang, 330000, China
2 Department of Ophthalmology, The Second Hospital Affiliated to Nanchang University, Nanchang, 330000, China

Correspondence Address:
Dr. Guodong Li
No. 1, Mingde Road, Donghu District, Nanchang City, Jiangxi Province, 330000
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_2902_21

Rights and Permissions

A 30-year-old Chinese woman presented to the ophthalmology department with bilateral blurry vision.; she was diagnosed with incomplete Vogt–Koyanagi–Harada (VKH). The treatment consisted of prednisolone infusion followed by a change of oral hormones. However, adalimumab subcutaneous injection was used instead because of the ineffectiveness of hormone therapy and the patient's reluctance to take oral hormones. After effective monotherapy with adalimumab, the inflammation was stable and inactive without recurrence at follow-up.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1052    
    Printed6    
    Emailed0    
    PDF Downloaded30    
    Comments [Add]    

Recommend this journal